CellSource Co., Ltd. Statistics
Want to see JP:4880 full AI Analyst Report?
CellSource Co., Ltd. (4880) Stock Statistics & Valuation Metrics
Total Valuation
CellSource Co., Ltd. has a market cap or net worth of JPY 5.58B. The enterprise value is JPY 1.70B.
- Market Cap
- JPY 5.58B
- Enterprise Value
- JPY 1.70B
Share Statistics
CellSource Co., Ltd. has 19,851,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 19,851,380
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
CellSource Co., Ltd.’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.24%.
- Return on Equity (ROE)
- 0.00
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 0.24%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 25.08M
- Profits Per Employee
- 72.02K
- Employee Count
- 148
- Asset Turnover
- 0.52
- Inventory Turnover
- 6.10
Valuation Ratios
The current PE Ratio of CellSource Co., Ltd. is 56.54. CellSource Co., Ltd.’s PEG ratio is 0.03.
- PE Ratio
- 56.54
- PS Ratio
- 1.62
- PB Ratio
- 0.92
- Price to FCF
- 19.24
- Price to Operating Cash Flow
- 16.75
- PEG Ratio
- 0.03
Income Statement
In the last 12 months, CellSource Co., Ltd. had revenue of 3.71B and earned 10.66M in profits. Earnings per share was 0.54.
- Revenue
- 3.71B
- Gross Profit
- 2.09B
- Operating Income
- 166.71M
- Pretax Income
- 109.85M
- Net Income
- 10.66M
- EBITDA
- 371.03M
- Earnings Per Share (EPS)
- 0.54
Cash Flow
In the last 12 months, operating cash flow was 333.10M and capital expenditures -43.19M, giving a free cash flow of 289.90M billion.
- Operating Cash Flow
- 333.10M
- Free Cash Flow
- 289.90M
- Free Cash Flow per Share
- 14.60
Dividends & Yields
CellSource Co., Ltd. pays an annual dividend of JPY 5.00, resulting in a dividend yield of 1.78%
- Dividend Per Share
- JPY 5.00
- Dividend Yield
- 1.78%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.20%
- Earnings Yield
- 1.77%
Stock Price Statistics
- Beta
- 0.92
- 52-Week Price Change
- -45.12%
- 50-Day Moving Average
- 313.64
- 200-Day Moving Average
- 347.00
- Relative Strength Index (RSI)
- 38.72
- Average Volume (3m)
- 67.14K
Important Dates
CellSource Co., Ltd. upcoming earnings date is Dec 08, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 08, 2026
- Next Earnings Date
- Dec 08, 2026
- Ex-Dividend Date
- Oct 30, 2025
Financial Position
CellSource Co., Ltd. as a current ratio of 12.39, with Debt / Equity ratio of 0.94%
- Current Ratio
- 12.39
- Quick Ratio
- 11.79
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -12.55
- Interest Coverage Ratio
- 126.87
Taxes
In the past 12 months, CellSource Co., Ltd. has paid 99.19M in taxes.
- Income Tax
- 99.19M
- Effective Tax Rate
- 0.90
Enterprise Valuation
CellSource Co., Ltd. EV to EBITDA ratio is 2.37, with an EV/FCF ratio of 3.00.
- EV to Sales
- 0.25
- EV to EBITDA
- 2.37
- EV to Free Cash Flow
- 3.00
- EV to Operating Cash Flow
- 2.61
Balance Sheet
CellSource Co., Ltd. has JPY 4.79B in cash and marketable securities with JPY 25.26M in debt, giving a net cash position of JPY 4.76B billion.
- Cash & Marketable Securities
- JPY 4.79B
- Total Debt
- JPY 25.26M
- Net Cash
- JPY 4.76B
- Net Cash Per Share
- JPY 239.85
- Tangible Book Value Per Share
- JPY 295.36
Margins
Gross margin is 57.90%, with operating margin of 6.45%, and net profit margin of 2.87%.
- Gross Margin
- 57.90%
- Operating Margin
- 6.45%
- Pretax Margin
- 6.04%
- Net Profit Margin
- 2.87%
- EBITDA Margin
- 10.64%
- EBIT Margin
- 6.45%
Analyst Forecast
The average price target for CellSource Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -9.94%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- ―
- AI Score
- 57
